Session

Other lower GI disorders (Posters)

ASSESSMENT OF SERUM ZONULIN AS A MARKER OF INTESTINAL PERMEABILITY AND IRRITABLE BOWEL SYNDROME DIAGNOSIS
ASSESSMENT OF SERUM ZONULIN AS A MARKER OF INTESTINAL PERMEABILITY AND IRRITABLE BOWEL SYNDROME DIAGNOSIS

Other lower GI disorders (Posters)  et al.

THE IMPACT OVERWEIGHT ON DIVERTICULAR DISEASE: A CASE CONTROL MULTICENTER STUDY
THE IMPACT OVERWEIGHT ON DIVERTICULAR DISEASE: A CASE CONTROL MULTICENTER STUDY

Other lower GI disorders (Posters)  et al.

THE GLUCAGON-LIKE PEPTIDE 1 ANALOGUE LIRAGLUTIDE IS SUPERIOR TO THE BILE ACID SEQUESTRANT COLESEVELAM IN REDUCING STOOL FREQUENCY IN BILE ACID MALABSORPTION
THE GLUCAGON-LIKE PEPTIDE 1 ANALOGUE LIRAGLUTIDE IS SUPERIOR TO THE BILE ACID SEQUESTRANT COLESEVELAM IN REDUCING STOOL FREQUENCY IN BILE ACID MALABSORPTION

Other lower GI disorders (Posters)  et al.

APPENDICEAL LESIONS IN SERRATED POLYPOSIS PATIENTS: HIGHLY PREVALENT BUT LOW MALIGNANT POTENTIAL
APPENDICEAL LESIONS IN SERRATED POLYPOSIS PATIENTS: HIGHLY PREVALENT BUT LOW MALIGNANT POTENTIAL

Other lower GI disorders (Posters)  et al.

THE EFFICACY OF MAGNIFIED ENDOSCOPIC OBSERVATION WITH NARROW BAND IMAGING AND BLUE LASER IMAGING FOR DIAGNOSING COLORECTAL SERRATED LESIONS
THE EFFICACY OF MAGNIFIED ENDOSCOPIC OBSERVATION WITH NARROW BAND IMAGING AND BLUE LASER IMAGING FOR DIAGNOSING COLORECTAL SERRATED LESIONS

Other lower GI disorders (Posters)  et al.

3 YEAR EVALUATION OF FAECAL IMMUNOCHEMICAL TEST (FIT) FOR PRIORITISATION OF URGENT COLORECTAL CANCER REFERRAL IN SYMPTOMATIC PATIENTS
3 YEAR EVALUATION OF FAECAL IMMUNOCHEMICAL TEST (FIT) FOR PRIORITISATION OF URGENT COLORECTAL CANCER REFERRAL IN SYMPTOMATIC PATIENTS

Other lower GI disorders (Posters)  et al.

EVALUATING THE MUCOADHESIVE PROPERTIES OF A THERAPEUTIC CONTAINING A COMBINATION OF XYLOGLUCAN, RETICULATED PROTEINS AND XYLOOLLIGOSACCHARIDES ON THE RESTORATION OF INTESTINAL BARRIER FUNCTION IN RATS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
EVALUATING THE MUCOADHESIVE PROPERTIES OF A THERAPEUTIC CONTAINING A COMBINATION OF XYLOGLUCAN, RETICULATED PROTEINS AND XYLOOLLIGOSACCHARIDES ON THE RESTORATION OF INTESTINAL BARRIER FUNCTION IN RATS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME

Other lower GI disorders (Posters)  et al.

EVALUATING THE EFFICACY OF A NATURAL THERAPEUTIC CONTAINING XYLOGLUCAN, PEA PROTEIN AND CHIA SEEDS EXTRACT ON A MURINE MODEL OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME
EVALUATING THE EFFICACY OF A NATURAL THERAPEUTIC CONTAINING XYLOGLUCAN, PEA PROTEIN AND CHIA SEEDS EXTRACT ON A MURINE MODEL OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME

Other lower GI disorders (Posters)  et al.

HIGH EXPRESSION OF BROTHER OF THE REGULATOR OF THE IMPRINTED SITE (BORIS) CYTOPLASM-LOCALIZED PROTEIN IS NOT ASSOCIATED WITH HIGH-RISK FEATURES OF COLORECTAL CANCER
HIGH EXPRESSION OF BROTHER OF THE REGULATOR OF THE IMPRINTED SITE (BORIS) CYTOPLASM-LOCALIZED PROTEIN IS NOT ASSOCIATED WITH HIGH-RISK FEATURES OF COLORECTAL CANCER

Other lower GI disorders (Posters)  et al.

PREMALIGNANT POLYPS, COLORECTAL CANCER AND THE 'SCOPE' FOR COLORECTAL CANCER SCREENING IN CYSTIC FIBROSIS: A 10 YEAR EXPERIENCE FROM A UK CENTRE
PREMALIGNANT POLYPS, COLORECTAL CANCER AND THE 'SCOPE' FOR COLORECTAL CANCER SCREENING IN CYSTIC FIBROSIS: A 10 YEAR EXPERIENCE FROM A UK CENTRE

Other lower GI disorders (Posters)  et al.

FIRST-LINE PALLIATIVE SYSTEMIC THERAPY ALTERNATED WITH ELECTROSTATIC PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (OXALIPLATIN) FOR ISOLATED UNRESECTABLE COLORECTAL PERITONEAL METASTASES: A MULTICENTRE, SINGLE-ARM, PHASE II STUDY (CRC-PIPAC-II)
FIRST-LINE PALLIATIVE SYSTEMIC THERAPY ALTERNATED WITH ELECTROSTATIC PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (OXALIPLATIN) FOR ISOLATED UNRESECTABLE COLORECTAL PERITONEAL METASTASES: A MULTICENTRE, SINGLE-ARM, PHASE II STUDY (CRC-PIPAC-II)

Other lower GI disorders (Posters)  et al.

DIAGNOSIS OF INTESTINAL MOTOR DYSFUNCTION USING HIGH-RESOLUTION JEJUNAL MANOMETRY
DIAGNOSIS OF INTESTINAL MOTOR DYSFUNCTION USING HIGH-RESOLUTION JEJUNAL MANOMETRY

Other lower GI disorders (Posters)  et al.

EFFECT OF COVID RELATED RESTRICTIONS ON IRRITABLE BOWEL SYNDROME PSYCHOLOGICAL WELL-BEING. A COMPARATIVE STUDY WITH ULCERATIVE COLITIS
EFFECT OF COVID RELATED RESTRICTIONS ON IRRITABLE BOWEL SYNDROME PSYCHOLOGICAL WELL-BEING. A COMPARATIVE STUDY WITH ULCERATIVE COLITIS

Other lower GI disorders (Posters)  et al.

NON-PHARMACOLOGICAL TREATMENT FOR CHILDREN WITH FUNCTIONAL CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
NON-PHARMACOLOGICAL TREATMENT FOR CHILDREN WITH FUNCTIONAL CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Other lower GI disorders (Posters)  et al.

THE MANAGEMENT OF IRRITABLE BOWEL SYNDROME: WHAT ARE THE PREFERENCES OF PATIENTS?
THE MANAGEMENT OF IRRITABLE BOWEL SYNDROME: WHAT ARE THE PREFERENCES OF PATIENTS?

Other lower GI disorders (Posters)  et al.

ROLE OF URGENT CONTRAST-ENHACED COMPUTED TOMOGRAPHY FOR ACUTE LOWER GASTROINTESTINAL BLEEDING BEFORE COLONOSCOPY AND EVALUATION OF PREDICTORS FOR EXTRAVASATION POSITIVE SIGN FROM JAPANESE MULTICENTER STUDY (CODE BLUE J- STUDY)
ROLE OF URGENT CONTRAST-ENHACED COMPUTED TOMOGRAPHY FOR ACUTE LOWER GASTROINTESTINAL BLEEDING BEFORE COLONOSCOPY AND EVALUATION OF PREDICTORS FOR EXTRAVASATION POSITIVE SIGN FROM JAPANESE MULTICENTER STUDY (CODE BLUE J- STUDY)

Other lower GI disorders (Posters)  et al.

RISKS AND HISTOPATHOLOGIC CHARACTERISTICS OF EARLY-ONSET COLORECTAL CANCER: A SINGLE CENTER STUDY
RISKS AND HISTOPATHOLOGIC CHARACTERISTICS OF EARLY-ONSET COLORECTAL CANCER: A SINGLE CENTER STUDY

Other lower GI disorders (Posters)  et al.

IDENTIFICATION OF AN AT-RISK SUBPOPULATION WITH HIGH IMMUNE INFILTRATION BASED ON PEROXISOME PATHWAY AND TIM3 IN COLORECTAL CANCER
IDENTIFICATION OF AN AT-RISK SUBPOPULATION WITH HIGH IMMUNE INFILTRATION BASED ON PEROXISOME PATHWAY AND TIM3 IN COLORECTAL CANCER

Other lower GI disorders (Posters)  et al.

PRIMARY AND SECONDARY BILE ACID DIARRHOEA ARE HIGHLY PREVALENT IN PATIENTS WITH SYMPTOMS COMPATIBLE WITH ROME IV IRRITABLE BOWEL SYNDROME-DIARRHOEA AND FUNCTIONAL DIARRHOEA
PRIMARY AND SECONDARY BILE ACID DIARRHOEA ARE HIGHLY PREVALENT IN PATIENTS WITH SYMPTOMS COMPATIBLE WITH ROME IV IRRITABLE BOWEL SYNDROME-DIARRHOEA AND FUNCTIONAL DIARRHOEA

Other lower GI disorders (Posters)  et al.

GENDER AND SUBTYPE-BASED DIFFERENCES IN FECAL SHORT-CHAIN FATTY ACIDS IN IRRITABLE BOWEL SYNDROME (IBS)
GENDER AND SUBTYPE-BASED DIFFERENCES IN FECAL SHORT-CHAIN FATTY ACIDS IN IRRITABLE BOWEL SYNDROME (IBS)

Other lower GI disorders (Posters)  et al.

Item 141 - 160 / 194
1 2 3 4 5 6 7
8
9 10